Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ACELRX PHARMA (NQ: ACRX)
7.450 USD  +0.190 (+2.62%)
Official Closing Price  /  Updated: 4:00 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 7.260
Bid (Size) 7.420 (200)
Ask (Size) 7.450 (100)
Prev. Close 7.260
Today's Range 6.800 - 7.650
52wk Range 2.270 - 7.420
Shares Outstanding 37,237,319
Dividend Yield N/A
Top News
More News
Bio-Wire Equity Surveillance – Closing Bell 5/22/2013
May 22, 2013
Notable Jumps by % Gain / Mkt Cap Change MannKind Corporation (NASDAQ: MNKD) +16.2 after Piper Jaffray analyst Ian Somaiya estimates a potential valuation of the company in the $3-4B range in the event... Read More
category Bio/Wire
from Bio-Wire.Com
Canaccord Boosts PT on AcelRx (ACRX) to $11; On Track for Sufentanil NDA Submission by Q313
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8361424 for the full story. Read More
from StreetInsider.com News Articles

More News
Read More
Free Research Reports on ACRX, SHLD, TJX and XEL Issued by the Paragon Report
May 22, 2013
from Marketwired News Releases
Market Wrap: Sprint Ponies Up for Clearwire; Herbalife Engages Auditor; 'One' for Microsoft
May 21, 2013
from StreetInsider.com News Articles
AcelRx Pharmaceuticals (ACRX) gains on positive test results
May 21, 2013
from BAYSTREET RSS FEED
StreetInsider.com Pre-Open Movers 5/21: (YGE) (SDBT) (ACRX) Higher; (HGG) (CCL) (BBY) Lower (more...)
May 21, 2013
from StreetInsider.com News Articles
AcelRx Pharma (ACRX) Stock Higher; Sufentanil NanoTab Study Meets Primary Endpoint
May 21, 2013
from StreetInsider.com News Articles
Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
May 21, 2013
from PR Newswire
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 16, 2013
from PR Newswire
AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
May 08, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here